bioMérieux Inc has announced the availability of the fourth performance level (Étage 4) for its STELLARA™ clinical-intervention and patient-monitoring software. The STELLARA system provides knowledge-enriched, infectious disease-specific recommendations to clinicians for medication treatment management. The availability of Étage 4 completes the bioMérieux suite of intelligent patient-therapy software systems and enables the clinician to capture a more comprehensive view of the patient to avoid potential medication errors and reduce the chances of costly adverse drug events (ADEs). The various stages of the STELLARA suite offer a range of capabilities and price points to better meet the needs and objectives of most institutions. STELLARA Étage 4 integrates the VITEK® bacterial identification and antibiotic susceptibility/resistance (ID/AST) system and laboratory information system results with patient-medication profiles to enable the pharmacist and clinician to make quicker and more accurate treatment decisions for the patient. The availability of this real-time information allows clinicians to rapidly match the identified bacteria to the most effective antibiotic(s). The Étage 4 level of functionality provides 90 predefined automated alerts, including medication errors and potential ADEs, as well as drug-level monitoring and antibiotic intervention with auto-recommendations. “STELLARA software is a key component of our integrated solutions initiative by linking key hospital personnel to the data and lab results generated throughout the hospital,” explains Eric Bouvier, bioMérieux’s North American president. “We developed the STELLARA system so it could be available at various performance and price levels to accommodate any size hospital. The Étage 4 provides the most advanced capabilities for a clinical-management system.” The Étage 4 upgrades any STELLARA system with additional capabilities, to present the right results to the right clinician at the right time, to enhance patient safety, to improve quality of care, and to provide significant hospital-wide savings. bioMérieux’s Web-based application operates on Palm® systems, offering mobility and real-time alerts for the clinician. Moreover, the system provides documented return on investment for the hospital. STELLARA is powered by TheraDoc® Inc, a Salt Lake City-based medical informatics company focused on clinical decision support.

bioMérieux Inc
(800) 682-2666; www.biomerieux.com